Clinical Trial Update: Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Hib-MenCY-TT vaccine to licensed Hib conjugate or meningococcal vaccine; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Disease
• Neisseria Meningitidis Disease

Drugs mentioned

• Hib-MenCY-TT
• Licensed Hib conjugate vaccine (Haemophilus influenzae type b conjugate vaccine)
• Meningococcal vaccine (Neisseria meningitidis vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 2 | Status: COMPLETED | Results posted: 2013-12-30